Showing results (171-180 of 237) with videos related to
Sort By:
Pageof 24
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|May 21, 2025
Phase II Study of Short Hydration without Diuretics for Cisplatin-Based ChemotherapyTetsuya Wako, Ryosuke Arakawa, Shinji Nakamichi, et al.Translational Lung Cancer Research|April 15, 2026
Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumoniasYuto Terashima, Aya Fukuizumi, Koichiro Kamio, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|January 17, 2024
Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive AnalysisYoshinobu Saito, Yasuhiro Terasaki, Takeru Kashiwada, et al.Japanese Journal of Clinical Oncology|September 19, 2024
A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancersSusumu Takeuchi, Akinobu Yoshimura, Atsushi Sofuni, et al.Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Survival benefit and potential markers of chemotherapy for elderly and poor performance status patients with advanced non-small cell lung cancer: Results from the Japanese Joint Committee of lung cancer registry databaseSatoshi Ikeda, Takashi Ogura, Etsuo Miyaoka, et al.Frontiers in Pharmacology|May 27, 2024
Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patientsTakeru Kashiwada, Ryotaro Takano, Fumihiko Ando, et al.JTO Clinical and Research Reports|November 8, 2021
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary FibrosisAya Fukuizumi, Rintaro Noro, Masahiro Seike, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFREisaku Miyauchi, Satoshi Morita, Atsushi Nakamura, et al.Oxford Medical Case Reports|October 27, 2018
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravisTakehiro Tozuka, Teppei Sugano, Rintaro Noro, et al.Thoracic Cancer|July 14, 2020
Poor efficacy of anti-programmed cell death-1/ligand 1 monotherapy for non-small cell lung cancer patients with active brain metastasesTakehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto, et al.Pageof 24